Both in Pharmaceuticals
Vanda Pharmaceuticals vs Immuneering
Over the past year VNDA returned −16.1% and IMRX returned −43.9%; their daily moves had a correlation of 0.27.
VNDA −16.1% IMRX −43.9%Growth of $1, one year, split-adjusted
| Metric | VNDA | IMRX |
|---|---|---|
| Price | $3.75 | $3.68 |
| Market cap | $226.8M | $238.3M |
| Today | −3.35% | +5.44% |
| 1 month | −18.1% | −8.9% |
| 6 months | −49.3% | −31.1% |
| Year to date | −57.5% | −44.1% |
| 1 year | −13.8% | −46.4% |
| Revenue growth (YoY) | +24.1% | — |
| Gross margin | 94.1% | — |
| Net margin | −32.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | — |
| Net cash | $138.1M | $145.4M |
| Dividend yield | — | — |
| Volatility (60d) | 39.0% | 53.8% |
| Short % of float | 15.4% | 29.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).